Insight Medbotics appoints CEO
By MRO staffBusiness Operations Industry Manufacturing Technology Machine Building Manufacturing artificial intelligence Board of Directors Insight Medbotics MRI-compatible robot robotics
Insight Medbotics’ Board of Directors, a medical device company combining the accuracy of MRI with the precision of robotics, has appointed Fazila Seker as chief executive officer. She will also serve on the company’s board of directors. Seker replaces Paul Chipperton, who was CEO and president for two years.
“We are delighted to welcome Fazila as Insight Medbotics’ new CEO,” said Dean Mosca, chairman of the Board of Directors, Insight Medbotics. “Her track record in the medical devices space, particularly in bringing early-stage technology to market while fostering strong, collaborative corporate cultures, made her an ideal choice.”
The company’s MRI-compatible robot, IGAR, has clinically demonstrated its use in breast biopsies for breast cancer patients. Other possible applications include therapeutic delivery and device placement.
Seker has nurtured new technologies through the commercialization process in Canada and the U.S. by building teams, raising growth funds, and bringing people together for impact in healthcare, energy, and specialty materials sectors. She served as Program Leader for GE Global Research Center in Niskayuna, NY; Director of Technology and Venture Development for MaRS Innovation in Toronto; and as President and CEO of MOLLI Surgical from 2018–2022.
After co-founding MOLLI Surgical, a Canadian company that develops devices to guide precision surgeries for a better patient experience, Fazila became the company’s first CEO. She led the company through FDA and Health Canada clearance for its flagship breast cancer surgery product. Under her leadership, MOLLI Surgical established sales and clinical operations in the U.S. and Canada.
In her new role, Seker will lead the Insight Medbotics team as they advance MRI-guided robotic technology to procedures where accuracy and precision matter most to patients, physicians and hospitals. She will also oversee the company’s partnerships, product development, and regulatory efforts.
“I’m excited to join Insight Medbotics’ team during this unprecedented era in health care. The convergence of more accessible MRI imaging, artificial intelligence and robotics together offer unique opportunities for our technology to improve quality of life for patients,” said Fazila Seker, CEO and member of the Board of Directors, Insight Medbotics. “I believe great teams do great things, and the quality of our board and clinical advisors gives me confidence in our ability to impact people’s lives in ways that weren’t possible before.”